This grant, offered for the continuation of the Cure Glomerulonephropathy (CureGN) Network, aims to extend crucial support to Participating Clinical Centers (PCCs). CureGN is a vital multicenter observational cohort study dedicated to improving care for glomerular disease patients. The PCCs will continue to follow previously enrolled participants while selectively enrolling new ones. Their primary objectives are to optimize participant retention strategies and develop innovative methods for remote or virtual study participation. Furthermore, PCCs are responsible for ensuring comprehensive and accurate data and biosample collection, with a specific focus on the clinical assessment of disease activity and outcomes. This initiative is pivotal for advancing understanding and treatment of glomerular diseases.
Opportunity ID: 349291
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DK-22-512 |
| Funding Opportunity Title: | Limited Competition for the Continuation of Cure Glomerulonephropathy (CureGN) Participating Clinical Centers (U01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Food and Nutrition Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 14, 2023 |
| Last Updated Date: | Jul 14, 2023 |
| Original Closing Date for Applications: | Oct 19, 2023 |
| Current Closing Date for Applications: | Oct 19, 2023 |
| Archive Date: | Nov 24, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments Public and State controlled institutions of higher education City or township governments Public housing authorities/Indian housing authorities Special district governments For profit organizations other than small businesses County governments Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Limited Competition is to extend the Cure Glomerulonephropathy (CureGN) Network by continuing to support the Participating Clinical Centers (PCCs). The CureGN Network is a multicenter observational cohort study of glomerular disease patients with the goal of improving care for all glomerular disease patients. The CureGN PCCs will continue to follow-up previously enrolled participants and enroll a limited number of new participants. The primary objective of the PCCs will be to optimize retention strategies, and methods for “remote” or “virtual” study participation; ensure complete and accurate data and biosample collection with a focus on clinical assessment of disease activity and outcomes. The DCC, under a separate NOFO, provides key leadership functions for this study in the areas of study organization, study design and implementation, and biosample management. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-22-512.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 349291 Full Announcement-RFA-DK-22-512 -> RFA-DK-22-512-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00282563 | Sep 19, 2023 | Oct 19, 2023 | View |
Package 1
Mandatory forms
349291 RR_SF424_5_0-5.0.pdf
349291 PHS398_CoverPageSupplement_5_0-5.0.pdf
349291 RR_OtherProjectInfo_1_4-1.4.pdf
349291 PerformanceSite_4_0-4.0.pdf
349291 RR_KeyPersonExpanded_4_0-4.0.pdf
349291 PHS398_ResearchPlan_5_0-5.0.pdf
349291 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
349291 RR_Budget_3_0-3.0.pdf
349291 RR_SubawardBudget30_3_0-3.0.pdf
349291 PHS398_ModularBudget_1_2-1.2.pdf
349291 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
